AIP
SLRN

Ameritas Investment Partners’s ACELYRIN SLRN Stock Holding History

Ameritas Investment Partners’s Portfolio SLRN Stock Details SLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-7,243
Closed -$17.9K – 3329
2025
Q1 		$17.9K Hold
7,243
– – ﹤0.01% 2603
2024
Q4 		$22.7K Hold
7,243
– – ﹤0.01% 2576
2024
Q3 		$35.7K Hold
7,243
– – ﹤0.01% 2384
2024
Q2 		$31.9K Hold
7,243
– – ﹤0.01% 2383
2024
Q1 		$48.9K Buy
7,243
+3,921
+118% +$29.8K ﹤0.01% 2157
2023
Q4 		$24.8K Hold
3,322
– – ﹤0.01% 2493
2023
Q3 		$33.8K Buy
+3,322
New +$70.6K ﹤0.01% 2306

Other funds holding SLRN

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Ameritas Investment Partners's SLRN Position: Q2 2025 in Review

Ameritas Investment Partners sold out of ACELYRIN (SLRN) in Q2 2025, closing a stake of 7,243 shares — an estimated $17.9K sold.

Ameritas Investment Partners first reported a position in SLRN in Q3 2023 and held it in 7 quarters. The position peaked at $48.9K in Q1 2024. 2 funds tracked by Wall St. Rank hold SLRN as of Q2 2025.

  • Ameritas Investment Partners reported no remaining ACELYRIN position as of Q2 2025 after selling out during the quarter.
  • Ameritas Investment Partners sold 7,243 ACELYRIN shares in Q2 2025, an estimated $17.9K.
  • Ameritas Investment Partners first reported a position in ACELYRIN in Q3 2023 and held it in 7 quarters.
  • Ameritas Investment Partners's ACELYRIN position peaked at $48.9K in Q1 2024.
  • 2 funds tracked by Wall St. Rank held ACELYRIN as of Q2 2025.

Based on Ameritas Investment Partners's 13F filing for Q2 2025, filed 12 Aug 2025.